0
From the Centers for Disease Control and Prevention | Morbidity and Mortality Weekly Report|

Severe Respiratory Illness Associated With a Novel Coronavirus — Saudi Arabia and Qatar, 2012 FREE

JAMA. 2012;308(20):2077-2078. doi:10.1001/jama.2012.31393.
Text Size: A A A
Published online

MMWR. 2012;40:820.

CDC is working closely with the World Health Organization (WHO) and other partners to better understand the public health risk presented by a recently detected, novel coronavirus. This virus has been identified in two patients, both previously healthy adults who suffered severe respiratory illness.12 The first patient, a man aged 60 years from Saudi Arabia, was hospitalized in June 2012 and died; the second patient, a man aged 49 years from Qatar with onset of symptoms in September 2012 was transported to the United Kingdom for intensive care. He remains hospitalized on life support with both pulmonary and renal failure.34 Person-to-person or health-care–associated transmission has not been identified to date.5 Interim case definitions based on acute respiratory illness and travel history were issued by WHO on September 29 and include criteria for “patient under investigation,” “probable case,” and “confirmed case.”6 This information is current as of October 4. Updates on the investigation and the WHO case definition are available at http://www.who.int/csr/don/en/index.html.

Coronaviruses are a large, diverse group of viruses that affect many animal species. A few of these viruses cause a wide range of respiratory illness in humans, typically with “common cold” symptoms. Genetic sequence data indicate that this new virus is a beta-coronavirus similar to bat coronaviruses, but not similar to any other coronavirus previously described in humans, including the coronavirus that caused severe acute respiratory syndrome (SARS).1 Comparison of viral genetic sequences from the two patients indicated that the two viruses are closely related. Treatment is supportive because no specific therapy has been shown to be effective.

WHO and CDC have not issued any travel alerts at this time. The risk to U.S. residents traveling in the region currently is estimated to be low. For persons traveling to Saudi Arabia to participate in the Hajj, scheduled for October 24-29, 2012, requirements and recommendations remain unchanged and can be found at http://www.cdc.gov/features/Hajj.

Persons who develop acute respiratory illness within 10 days after returning from Saudi Arabia or Qatar (excluding persons who only passed through airports) should consult a physician and mention their recent travel. Persons with acute severe lower respiratory illness requiring hospitalization should be evaluated using the guidance at the CDC coronavirus website (http://www.cdc.gov/coronavirus/ncv), which is based on the WHO case definition. Persons whose respiratory illness remains unexplained and who meet the WHO criteria for “patient under investigation” should be reported immediately to CDC through state and local health departments. At present, testing of specimens for the novel coronavirus will be conducted by CDC; widely available diagnostic tests for coronaviruses are not suitable for detecting this new virus.

Recommendations and guidance on the case definitions, infection control including personal protective equipment, case investigation, and specimen collection and shipment, are available at the CDC coronavirus website. Because of the possibility of frequent updates as new information becomes available, readers are encouraged to consult the CDC coronavirus website for current information. State and local health departments with questions should contact the CDC Emergency Operations Center (770-488-7100).

Reported by: Div of Viral Diseases, National Center for Immunization and Respiratory Diseases; Div of Healthcare Quality Promotion, Div of Global Migration and Quarantine, National Center for Emerging and Zoonotic infectious Diseases; Div of Global Disease Detection and Emergency Response, Center for Global Health; Eyal Leshem, MD, EIS Officer, CDC. Corresponding contributor: Eyal Leshem, eleshem@cdc.gov, 404-639-7251.

On October 4, 2012, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr).

REFERENCES

Corman VM, Eckerle I, Bleicker T,  et al.  Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction.  Euro Surveill. 2012;17(39):
PubMed
Danielsson N, Catchpole M.ECDC Internal Response Team.  Novel coronavirus associated with severe respiratory disease: Case definition and public health measures.  Euro Surveill. 2012;17(39):
PubMed
Bermingham A, Chand MA, Brown CS,  et al.  Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.  Euro Surveill. 2012;17(40):
European Centre for Disease Prevention and Control (ECDC).  Rapid risk assessment: severe respiratory disease associated with a novel coronavirus. Stockholm, Sweden: ECDC; 2012. Available at http://ecdc.europa.eu/en/publications/Publications/RRA-Novel-coronavirus-final20120924.pdf. Accessed October 4, 2012
Pebody RG, Chand MA, Thomas HL,  et al.  The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012.  Euro Surveill. 2012;17(40):
PubMed
World Health Organization.  Global alert and response (GAR): revised interim case definition—novel coronavirus. Geneva, Switzerland: World Health Organization; 2012. Available at http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/index.html. Accessed October 4, 2012

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Corman VM, Eckerle I, Bleicker T,  et al.  Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction.  Euro Surveill. 2012;17(39):
PubMed
Danielsson N, Catchpole M.ECDC Internal Response Team.  Novel coronavirus associated with severe respiratory disease: Case definition and public health measures.  Euro Surveill. 2012;17(39):
PubMed
Bermingham A, Chand MA, Brown CS,  et al.  Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.  Euro Surveill. 2012;17(40):
European Centre for Disease Prevention and Control (ECDC).  Rapid risk assessment: severe respiratory disease associated with a novel coronavirus. Stockholm, Sweden: ECDC; 2012. Available at http://ecdc.europa.eu/en/publications/Publications/RRA-Novel-coronavirus-final20120924.pdf. Accessed October 4, 2012
Pebody RG, Chand MA, Thomas HL,  et al.  The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012.  Euro Surveill. 2012;17(40):
PubMed
World Health Organization.  Global alert and response (GAR): revised interim case definition—novel coronavirus. Geneva, Switzerland: World Health Organization; 2012. Available at http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/index.html. Accessed October 4, 2012
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics